Sign Out
Pregnancy: Caution: Safe use of this product in pregnancy has not been established. The use of FREENOS SR during pregnancy is therefore not recommended.
Lactation: Loratadine and its active metabolite are eliminated in the breast milk of lactating women with milk concentrations being similar to plasma concentrations. Through 48 hours after dosing, only 0.029% of the loratadine dose is eliminated in the milk as unchanged loratadine and its active metabolite, descarboethoxy-loratadine. Pseudoephedrine has been reported to be excreted into breast milk of lactating women. The use of FREENOS SR in nursing mothers is therefore not recommended.
